Search

Search Constraints

You searched for: Author/Creator Luebke, Andreas M.

Search Results

1. 5q21 deletion is often heterogeneous in prostate cancer. Issue 8 (24th January 2019)

2. Apurinic/apyrimidinic endonuclease 1 (APE1/Ref‐1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion. Issue 9 (22nd May 2017)

3. Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas. (January 2022)

4. Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16, 000 Tumors. (8th August 2022)

5. High B7‐H3 expression is linked to increased risk of prostate cancer progression. Issue 10 (10th August 2020)

6. High density of cytotoxic T-lymphocytes is linked to tumoral PD-L1 expression regardless of the mismatch repair status in colorectal cancer. (2nd September 2021)

7. Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder. (2nd May 2019)

8. Kidney Transplantation after Extended Multivisceral Resection for Pancreatic Ductal Adenocarcinoma. (26th July 2018)

9. Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion‐positive prostate cancers. Issue 2 (18th March 2020)

10. MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10 399 Tissue Samples. (September 2021)